Clinical Trial Update: Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating Endostar in combination with vinorelbine and cisplatin as second-line therapy for advanced esophageal squamous cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Endostar (recombinant human endostatin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN